Studying TAK-243 in Patients With Advanced Cancer

Clinical trial NCT06223542 · RECRUITING

Trial details

NCT number: NCT06223542
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Lymphoma Advanced Malignant Solid Neoplasm Indolent Non-Hodgkin Lymphoma Metastatic Malignant Solid Neoplasm Recurrent Malignant Solid Neoplasm Refractory Malignant Solid Neoplasm

Start date: 2025-03-24
Primary completion: 2027-04-15
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.